FDA moves to ban fluoride tablets amid rising health concerns

In recent months, the FDA has indicated plans to ban fluoride tablets and drops prescribed to children in places where fluoride is not added to the drinking water. On July 23, 2025, the agency conducted a public meeting featuring various experts and stakeholders to discuss the implications of this potential ban. Traditionally, fluoride is recognized for its effectiveness in preventing cavities in children and has been routinely added to public drinking water for several decades. However, some state governments are initiating measures to ban this practice, creating a divide in public health policy regarding fluoride use. The FDA's announcement comes as health experts express increasing concerns about the prescription of fluoride supplements—highlighting that these products have never formally been approved by the agency. FDA Commissioner Dr. Marty Makary stated that there is a potential risk associated with ingesting fluoride due to its possible effects on gut microbiomes, prompting discussions regarding alternative methods for dental health. The proposed ban has garnered support from some sectors, including Health Secretary Robert F. Kennedy, Jr., who believes it's necessary for the protection of children's health. Conversely, proponents of fluoride argue that the benefits—such as cavity prevention and enamel strengthening—outweigh the risks presented. The American Academy of Pediatric Dentistry supports daily fluoride use for children and advises that measures be taken to ensure accessibility to these products, especially as community fluoridation efforts face challenges. Notably, a poll indicated that most Americans still favor water fluoridation, reflecting public support for the benefits of fluoride despite the emerging discussions around its risks. As debates continue, the FDA is expected to finalize its decision by October 2025, amidst growing scrutiny and calls for further research on fluoride's safety. The proposed ban may impact prescription rates, which have already begun declining in recent years. Fluctuations in fluoride prescription have been observed to correlate with the varying availability of community fluoridation, indicating a complex interaction between public policy, health recommendations, and parental concerns over dental health and safety. The FDA's impending decision will likely influence both these prescriptions and the ongoing dialogue on the necessity of fluoride in combating tooth decay amongst children.